Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

CyberHeart brings in $2.2mm so far through its Series B round

Executive Summary

CyberHeart Inc. (noninvasive radiosurgical system for cardiac arrhythmias) has raised $2.2mm through its Series B venture round to 16 undisclosed investors. According to the company’s Form D, it may bring in another $557k before closing the financing. CyberHeart brought in $9mm via its 2008 round and $3.6mm from a debt sale in late 2009.

Deal Industry
  • Medical Devices
  • Medical Devices
    • Radiofrequency Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register